Skaar, who directs the Vanderbilt Institute for Infection, Immunology and Inflammation, is being recognized for “pioneering work at the intersection of nutrition and infectious diseases."

A 17-year-old cystic fibrosis warrior and liver transplant recipient with antibiotic resistance got to see science in action at Vanderbilt Medical Laboratories.

The list recognizes both the scientific achievements of individual scientists and “their profound impact on tackling broader societal challenges.”

The study findings point to the potential of interleukin-13 antibodies — approved for use in humans — as a treatment to protect against bacterial pneumonia in patients with zinc deficiency.

Crowe and his colleagues have developed cutting-edge technologies to isolate and study antiviral antibodies.

The discovery, reported in the journal PLOS Pathogens, could help open the door to the development of effective vaccines and antibody therapies with an “exceptional breadth of pathogen coverage.”

The mechanistic understanding of how cells respond to heat could explain how chronic inflammation contributes to the development of cancer.